Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06269510 · ClinicalTrials.gov registry record · NA
Enhancing Alcohol Treatment Engagement in Associated Liver Disease (ALD) Patients
A NA study of Liver Diseases and Alcohol-related Liver Disease, sponsored by Henry Ford Health System.
- Recruiting
- Registry status
- NA
- Development phase
- 268
- Enrollment target
- 1
- Study location
NCT06269510 is a NA study of Liver Diseases and Alcohol-related Liver Disease that is actively recruiting participants, run by Henry Ford Health System. The registered enrollment target is 268 participants, below the 61,150-participant average among 33 other Liver Diseases trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06269510, a NA study of Liver Diseases and Alcohol-related Liver Disease, is actively recruiting participants, sponsored by Henry Ford Health System.
- RECRUITING
- Registry status
- NA
- Development phase
- 268 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this trial is to see if providing patients with alcohol-related liver disease with tailored alcohol use treatment options will increase engagement with treatment and correct possible misconceptions.
Conditions Studied
Interventions
- BEHAVIORAL Enhanced Usual Care
- BEHAVIORAL ENGAGE-ALD Application (APP)
- BEHAVIORAL Treatment Facilitation bundle
Study Locations (1)
Michigan
- Henry Ford Health - Detroit
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 268 participants |
| Start Date | 2026-01-28 |
| Est. Completion | 2030-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06269510
The ClinicalTrials.gov registry entry for NCT06269510 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 268 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 61,150-participant average among 33 other Liver Diseases trials with a reported enrollment target (100% lower). The listed sponsor is Henry Ford Health System, which has 234 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Liver Diseases appearing as the primary indexed condition, and to 3 interventions - of which Enhanced Usual Care is the first listed.
NCT06269510 reports 1 study location spanning 1 distinct geographic area - top geographies include Michigan.
Frequently Asked Questions
What is clinical trial NCT06269510 about?
NCT06269510 is a clinical study titled "Enhancing Alcohol Treatment Engagement in Associated Liver Disease (ALD) Patients". The purpose of this trial is to see if providing patients with alcohol-related liver disease with tailored alcohol use treatment options will increase engagement with treatment and correct possible misconceptions.
What is the current status of trial NCT06269510?
This trial is currently recruiting. It is a NA study. The enrollment target is 268 participants. The study started on 2026-01-28. Estimated completion is 2030-02.
What conditions does trial NCT06269510 study?
This clinical trial studies the following conditions: Liver Diseases, Alcohol-related Liver Disease.
What interventions are being tested in trial NCT06269510?
The interventions under investigation include: Enhanced Usual Care (BEHAVIORAL), ENGAGE-ALD Application (APP) (BEHAVIORAL), Treatment Facilitation bundle (BEHAVIORAL).
Who is sponsoring clinical trial NCT06269510?
This trial is sponsored by Henry Ford Health System, which has 234 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06269510 being conducted?
This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Liver Diseases
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Veteran-Centered Care for Advanced Liver Disease (Vet-CALD)
RECRUITING · NA
-
Effect of Endoscopic Sleeve Gastroplasty in Patients With Obesity and MASH: A Randomized Controlled Trial
RECRUITING · NA
-
A Trial of Post-Discharge Transitional Care for Patients With Chronic Liver Disease
RECRUITING · NA
-
Safety and Efficacy of Endoscopic Ultrasound-Guided Portal Pressure Gradient Measurement
RECRUITING · NA
-
Liver Cancer Prevention Randomized Control Trial
ACTIVE NOT RECRUITING · NA
-
Implementation of a Digital Clinic for Alcohol-associated Liver Disease and Alcohol Use Disorder (DALC)
ACTIVE NOT RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.